Unicancer

Unicancer is the only French hospital network 100% dedicated to the fight against cancer and the only national hospital federation dedicated to cancer. It brings together 19 French comprehensive cancer centres (Fcccs), private not-for-profit health facilities, as well as one affiliated centre, spread over 21 hospital sites in France. The Fcccs take care of nearly 530,000 patients per year (in short-stay, home-based hospitalization and outpatient procedures). Unicancer is also the leading academic promoter of clinical trials in oncology, on a European scale, with 106 active clinical trials promoted, approximately 7,600 patients included and 63,000 patients registered in the ESME database. Recognized as a leader in research in France, the Unicancer network enjoys a worldwide reputation with the production of one third of French publications of international renown in oncology (source: bibliometric study/Thomson Reuters). In total, approximately 700 clinical trials (inclusion or follow-up) have been promoted in 2020 by the Unicancer network, more than 14% of Fcccs patients are included in clinical trials and more than half of the PHRCs devolved to Fcccs. The Fcccs and Unicancer's R&D department are ISO 9001:2015 certified for their clinical research.